Published in J Exp Med on December 16, 2002
Complement: a key system for immune surveillance and homeostasis. Nat Immunol (2010) 10.37
Disruption of E-cadherin-mediated adhesion induces a functionally distinct pathway of dendritic cell maturation. Immunity (2007) 3.58
Pathogenesis of human systemic lupus erythematosus: recent advances. Trends Mol Med (2010) 2.35
TLR-signaling networks: an integration of adaptor molecules, kinases, and cross-talk. J Dent Res (2010) 2.14
Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory. J Exp Med (2004) 2.10
Binding of the Fap2 protein of Fusobacterium nucleatum to human inhibitory receptor TIGIT protects tumors from immune cell attack. Immunity (2015) 1.92
Saturated-efferocytosis generates pro-resolving CD11b low macrophages: modulation by resolvins and glucocorticoids. Eur J Immunol (2010) 1.70
IgM antibodies to apoptosis-associated determinants recruit C1q and enhance dendritic cell phagocytosis of apoptotic cells. J Immunol (2009) 1.62
Complement System Part I - Molecular Mechanisms of Activation and Regulation. Front Immunol (2015) 1.52
MerTK is required for apoptotic cell-induced T cell tolerance. J Exp Med (2008) 1.48
The apoptotic-cell receptor CR3, but not alphavbeta5, is a regulator of human dendritic-cell immunostimulatory function. Blood (2006) 1.37
Interactions of tumor cells with dendritic cells: balancing immunity and tolerance. Cell Death Differ (2007) 1.35
C1q differentially modulates phagocytosis and cytokine responses during ingestion of apoptotic cells by human monocytes, macrophages, and dendritic cells. J Immunol (2009) 1.32
Complement System Part II: Role in Immunity. Front Immunol (2015) 1.31
Factors and signals that govern the migration of dendritic cells via lymphatics: recent advances. Springer Semin Immunopathol (2005) 1.25
The chemokine receptor CCR7 mediates corneal antigen-presenting cell trafficking. Mol Vis (2007) 1.16
Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum Immunol (2007) 1.03
New concepts of complement in allorecognition and graft rejection. Cell Immunol (2007) 1.02
Apoptosis is essential for the increased efficacy of alphaviral replicase-based DNA vaccines. Vaccine (2004) 1.02
Apoptotic cell-based therapies against transplant rejection: role of recipient's dendritic cells. Apoptosis (2010) 1.01
HIV-1 matrix protein p17 induces human plasmacytoid dendritic cells to acquire a migratory immature cell phenotype. Proc Natl Acad Sci U S A (2008) 0.98
In situ-targeting of dendritic cells with donor-derived apoptotic cells restrains indirect allorecognition and ameliorates allograft vasculopathy. PLoS One (2009) 0.97
Role of dendritic cell maturity/costimulation for generation, homeostasis, and suppressive activity of regulatory T cells. Front Immunol (2011) 0.96
Functional roles of immature dendritic cells in impaired immunity of solid tumour and their targeted strategies for provoking tumour immunity. Clin Exp Immunol (2006) 0.96
Impaired clearance of apoptotic cells in chronic inflammatory diseases: therapeutic implications. Front Immunol (2014) 0.93
Recent advances in dendritic cell biology. J Clin Immunol (2005) 0.92
Expansion of CD4+ CD25+ Foxp3+ T cells by bone marrow-derived dendritic cells. Immunology (2009) 0.91
Dendritic cells transduced with lentiviral vectors expressing VIP differentiate into VIP-secreting tolerogenic-like DCs. Mol Ther (2010) 0.91
C3 opsonization regulates endocytic handling of apoptotic cells resulting in enhanced T-cell responses to cargo-derived antigens. Proc Natl Acad Sci U S A (2014) 0.89
Acquisition and presentation of follicular dendritic cell-bound antigen by lymph node-resident dendritic cells. J Exp Med (2010) 0.88
The induction of APC with a distinct tolerogenic phenotype via contact-dependent STAT3 activation. PLoS One (2009) 0.87
Dendritic Cells (DC) Facilitate Detachment of Squamous Carcinoma Cells (SCC), While SCC Promote an Immature CD16(+) DC Phenotype and Control DC Migration. Cancer Microenviron (2011) 0.85
'Danger' effect of low-density lipoprotein (LDL) and oxidized LDL on human immature dendritic cells. Clin Exp Immunol (2007) 0.85
Complement opsonization of HIV-1 results in decreased antiviral and inflammatory responses in immature dendritic cells via CR3. J Immunol (2014) 0.84
Complement opsonization of HIV-1 enhances the uptake by dendritic cells and involves the endocytic lectin and integrin receptor families. PLoS One (2011) 0.83
How apoptotic β-cells direct immune response to tolerance or to autoimmune diabetes: a review. Apoptosis (2015) 0.81
Transplant tolerance: new insights and strategies for long-term allograft acceptance. Clin Dev Immunol (2013) 0.80
Thrombospondin-1-N-terminal domain induces a phagocytic state and thrombospondin-1-C-terminal domain induces a tolerizing phenotype in dendritic cells. PLoS One (2009) 0.80
Protection of host cells by complement regulators. Immunol Rev (2016) 0.79
Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice. PLoS One (2012) 0.79
Activation outcomes induced in naïve CD8 T-cells by macrophages primed via "phagocytic" and nonphagocytic pathways. Mol Biol Cell (2007) 0.79
Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake. Front Biosci (Landmark Ed) (2009) 0.79
Concise Review: Mechanisms Behind Apoptotic Cell-Based Therapies Against Transplant Rejection and Graft versus Host Disease. Stem Cells (2016) 0.78
Hyperactivation of the alternative complement cascade in schizophrenia. Dokl Biochem Biophys (2008) 0.77
Apoptotic cells induce NF-κB and inflammasome negative signaling. PLoS One (2015) 0.76
Innate and humoral recognition of the products of cell death: differential antigenicity and immunogenicity in lupus. Clin Exp Immunol (2016) 0.75
Antibody Targeting of "Steady-State" Dendritic Cells Induces Tolerance Mediated by Regulatory T Cells. Front Immunol (2016) 0.75
Identification and Characterization of Two Human Monocyte-Derived Dendritic Cell Subpopulations with Different Functions in Dying Cell Clearance and Different Patterns of Cell Death. PLoS One (2016) 0.75
Immunochemical composition of cryoglobulins generated in stroke. J Clin Immunol (2008) 0.75
Regulator-dependent mechanisms of C3b processing by factor I allow differentiation of immune responses. Nat Struct Mol Biol (2017) 0.75
Dendritic cells and the control of immunity. Nature (1998) 56.54
CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell (1999) 12.50
Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs. Nature (1998) 9.77
Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet (1998) 8.20
Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites. J Exp Med (1998) 6.12
A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature (2000) 6.12
Corpse clearance defines the meaning of cell death. Nature (2000) 6.01
The induction of tolerance by dendritic cells that have captured apoptotic cells. J Exp Med (2000) 5.74
Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J Exp Med (1998) 5.59
Fcgamma receptor-mediated induction of dendritic cell maturation and major histocompatibility complex class I-restricted antigen presentation after immune complex internalization. J Exp Med (1999) 5.55
Phagocyte recognition of cells undergoing apoptosis. Immunol Today (1993) 4.77
C1q and mannose binding lectin engagement of cell surface calreticulin and CD91 initiates macropinocytosis and uptake of apoptotic cells. J Exp Med (2001) 4.54
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation. Eur J Immunol (1998) 4.51
A novel role for the beta 2 integrin CD11b/CD18 in neutrophil apoptosis: a homeostatic mechanism in inflammation. Immunity (1996) 4.03
A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo. J Exp Med (2000) 3.65
Efficient presentation of phagocytosed cellular fragments on the major histocompatibility complex class II products of dendritic cells. J Exp Med (1998) 3.58
Complement receptor type three (CD11b/CD18) of human polymorphonuclear leukocytes recognizes fibrinogen. Proc Natl Acad Sci U S A (1988) 3.25
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol (1993) 3.19
Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Pharmacol Rev (1998) 3.05
Systemic exposure to irradiated apoptotic cells induces autoantibody production. J Exp Med (1998) 3.01
The alpha 5 beta 1 integrin supports survival of cells on fibronectin and up-regulates Bcl-2 expression. Proc Natl Acad Sci U S A (1995) 2.90
Differential regulation of chemokine receptors during dendritic cell maturation: a model for their trafficking properties. J Immunol (1998) 2.70
Complement-dependent clearance of apoptotic cells by human macrophages. J Exp Med (1998) 2.69
Reversal of proinflammatory responses by ligating the macrophage Fcgamma receptor type I. J Exp Med (1998) 2.55
Mobilizing dendritic cells for tolerance, priming, and chronic inflammation. J Exp Med (1999) 2.37
EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol (1998) 2.27
Tumor-specific killer cells in paraneoplastic cerebellar degeneration. Nat Med (1998) 2.11
Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med (1997) 2.09
Salmonella-induced apoptosis of infected macrophages results in presentation of a bacteria-encoded antigen after uptake by bystander dendritic cells. J Exp Med (2000) 2.01
Trans-dominant inhibition of integrin function. Mol Biol Cell (1996) 1.92
Neutrophil and monocyte cell surface p150,95 has iC3b-receptor (CR4) activity resembling CR3. J Clin Invest (1988) 1.92
Dissociation of phagocytosis from stimulation of the oxidative metabolic burst in macrophages. J Exp Med (1984) 1.85
The CC chemokine receptor-7 ligands 6Ckine and macrophage inflammatory protein-3 beta are potent chemoattractants for in vitro- and in vivo-derived dendritic cells. J Immunol (1999) 1.73
Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells. J Exp Med (2000) 1.62
Ligated complement receptors do not activate the arachidonic acid cascade in resident peritoneal macrophages. J Exp Med (1985) 1.60
The selective engulfment of apoptotic bodies by dendritic cells is mediated by the alpha(v)beta3 integrin and requires intracellular and extracellular calcium. Eur J Immunol (1997) 1.50
Cr2, a candidate gene in the murine Sle1c lupus susceptibility locus, encodes a dysfunctional protein. Immunity (2001) 1.36
Complement and apoptosis. Mol Immunol (2001) 1.35
Dendritic cells capture killed tumor cells and present their antigens to elicit tumor-specific immune responses. J Immunol (2000) 1.33
Suppression of Il-12 transcription in macrophages following Fc gamma receptor ligation. J Immunol (2001) 1.29
Cytokines regulate proteolysis in major histocompatibility complex class II-dependent antigen presentation by dendritic cells. J Exp Med (2001) 1.21
Cloning of human and mouse EBI1, a lymphoid-specific G-protein-coupled receptor encoded on human chromosome 17q12-q21.2. Genomics (1994) 1.16
Expression of the chemokine receptor BLR2/EBI1 is specifically transactivated by Epstein-Barr virus nuclear antigen 2. Biochem Biophys Res Commun (1995) 1.14
Outside-in signaling by lipopolysaccharide through a tailless integrin. J Immunol (1997) 1.11
Opsonization of apoptotic cells. Implications for uptake and autoimmunity. Ann N Y Acad Sci (2000) 0.97
Activation of the alternative pathway of complement by apoptotic Jurkat cells. FEBS Lett (1994) 0.93
Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood (2004) 4.04
Inhibition of the NKp30 activating receptor by pp65 of human cytomegalovirus. Nat Immunol (2005) 2.55
Burnout and risk of cardiovascular disease: evidence, possible causal paths, and promising research directions. Psychol Bull (2006) 2.01
Relation of educational level to inflammation-sensitive biomarker level. Am J Cardiol (2008) 1.64
Predictive value of high sensitivity CRP in patients with diastolic heart failure. Int J Cardiol (2007) 1.63
Retracted Novel APC-like properties of human NK cells directly regulate T cell activation. J Clin Invest (2004) 1.58
The Thr224Asn mutation in the VPS45 gene is associated with the congenital neutropenia and primary myelofibrosis of infancy. Blood (2013) 1.55
Burnout and risk of type 2 diabetes: a prospective study of apparently healthy employed persons. Psychosom Med (2006) 1.52
Vitamin K-dependent coagulation factors and fibrinogen levels in FFP remain stable upon repeated freezing and thawing. Transfusion (2003) 1.45
Asthma in adventure travelers: a prospective study evaluating the occurrence and risk factors for acute exacerbations. Arch Intern Med (2002) 1.45
Attempted forced titration of blood pressure to <130/85 mm Hg in type 2 diabetic hypertensive patients in clinical practice: the diastolic cost. J Clin Hypertens (Greenwich) (2006) 1.41
The association between burnout, depression, anxiety, and inflammation biomarkers: C-reactive protein and fibrinogen in men and women. J Occup Health Psychol (2005) 1.31
On the nature of burnout-insomnia relationships: a prospective study of employed adults. J Psychosom Res (2008) 1.16
Short-term exposure to air pollution and inflammation-sensitive biomarkers. Environ Res (2007) 1.11
Platelet counts and platelet activation markers in obese subjects. Mediators Inflamm (2008) 1.10
An antibody profile of systemic lupus erythematosus detected by antigen microarray. Immunology (2010) 1.08
Revascularization of the right coronary artery in bilateral internal thoracic artery grafting. Ann Thorac Surg (2005) 1.06
Serum cholinesterase activities distinguish between stroke patients and controls and predict 12-month mortality. Mol Med (2010) 1.04
Apoptotic cells inhibit LPS-induced cytokine and chemokine production and IFN responses in macrophages. Hum Immunol (2007) 1.03
Apoptotic cell thrombospondin-1 and heparin-binding domain lead to dendritic-cell phagocytic and tolerizing states. Blood (2006) 1.03
CD59 deficiency is associated with chronic hemolysis and childhood relapsing immune-mediated polyneuropathy. Blood (2012) 1.02
iC3b-opsonized apoptotic cells mediate a distinct anti-inflammatory response and transcriptional NF-kappaB-dependent blockade. Eur J Immunol (2010) 1.01
Environmental air pollution has decremental effects on pulmonary function test parameters up to one week after exposure. Am J Med Sci (2009) 1.01
Donor anti-Jk(a) causing hemolysis in a liver transplant recipient. Transfusion (2002) 1.00
Burnout and risk of coronary heart disease: a prospective study of 8838 employees. Psychosom Med (2012) 0.97
Increased morbidity and mortality in patients with antiphospholipid syndrome undergoing valve replacement surgery. J Thorac Cardiovasc Surg (2004) 0.97
Translocation of active heparanase to cell surface regulates degradation of extracellular matrix heparan sulfate upon transmigration of mature monocyte-derived dendritic cells. J Immunol (2006) 0.94
The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation. Thromb Res (2006) 0.93
The association of higher levels of within-normal-limits liver enzymes and the prevalence of the metabolic syndrome. Cardiovasc Diabetol (2010) 0.92
Low-grade inflammation in individuals with the hypertriglyceridemic waist phenotype: another feature of the atherogenic dysmetabolism. Metabolism (2009) 0.91
Early signaling of inflammation in acute ischemic stroke: clinical and rheological implications. Thromb Res (2007) 0.91
Micro-inflammatory changes in asymptomatic healthy adults during bouts of respiratory tract infections in the community: potential triggers for atherothrombotic events. Atherosclerosis (2009) 0.90
Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol (2009) 0.89
Erythrocyte adhesiveness/aggregation: a novel biomarker for the detection of low-grade internal inflammation in individuals with atherothrombotic risk factors and proven vascular disease. Am Heart J (2005) 0.88
Association of fear of terror with low-grade inflammation among apparently healthy employed adults. Psychosom Med (2004) 0.88
The effects of physical fitness and feeling vigorous on self-rated health. Health Psychol (2008) 0.87
Exploring the usefulness of inflammation-sensitive biomarkers to reveal potential sex differences in relation to low-grade inflammation in individuals with the metabolic syndrome. Metabolism (2008) 0.87
Association of components of the metabolic syndrome with the appearance of aggregated red blood cells in the peripheral blood. An unfavorable hemorheological finding. Diabetes Metab Res Rev (2005) 0.87
Effect of tumor necrosis factor-alpha on endothelial and inducible nitric oxide synthase messenger ribonucleic acid expression and nitric oxide synthesis in ischemic and nonischemic isolated rat heart. J Am Coll Cardiol (2003) 0.87
Predictors for poststroke outcomes: the Tel Aviv Brain Acute Stroke Cohort (TABASCO) study protocol. Int J Stroke (2011) 0.86
Accelerated autoimmune disease in MRL/MpJ-Fas(lpr) but not in MRL/MpJ following immunization with high load of syngeneic late apoptotic cells. Autoimmunity (2004) 0.86
Glycohaemoglobin as a determinant of increased fibrinogen concentrations and low-grade inflammation in apparently healthy nondiabetic individuals. Clin Endocrinol (Oxf) (2007) 0.85
Constitutive neutrophil apoptosis: regulation by cell concentration via S100 A8/9 and the MEK-ERK pathway. PLoS One (2012) 0.85
Effectiveness of prehospital synchronous direct-current cardioversion for supraventricular tachyarrhythmias causing unstable hemodynamic states. Am J Cardiol (2003) 0.85
Increased intracranial pressure related to systemic lupus erythematosus: a 26-year experience. Semin Arthritis Rheum (2008) 0.84
Acute renal failure and interstitial nephritis in a patient treated with rofecoxib: case report and review of the literature. Arthritis Rheum (2004) 0.84
Enoxaparin can be used safely in patients with severe thrombocytopenia due to intensive chemotherapy regimens. Leuk Lymphoma (2004) 0.84
Values of high-sensitivity C-reactive protein in each month of the year in apparently healthy individuals. Am J Cardiol (2005) 0.84
Altered dendritic cells with tolerizing phenotype in patients with systemic lupus erythematosus. Eur J Immunol (2008) 0.84
Introducing the wide range C-reactive protein (wr-CRP) into clinical use for the detection of microinflammation. Clin Chim Acta (2005) 0.83
The effect of two iso-caloric meals containing equal amounts of fats with a different fat composition on the inflammatory and metabolic markers in apparently healthy volunteers. J Inflamm (Lond) (2013) 0.83
Ethnic groups and high sensitivity C-reactive protein in Israel. Biomarkers (2008) 0.83
Enhanced erythrocyte adhesiveness/aggregation in obesity corresponds to low-grade inflammation. Obes Res (2003) 0.83
Elevated burnout predicts the onset of musculoskeletal pain among apparently healthy employees. J Occup Health Psychol (2010) 0.83
Automated system to detect low-grade underlying inflammatory profile: Gaucher disease as a model. Blood Cells Mol Dis (2004) 0.82
Cognitive decline after stroke: relation to inflammatory biomarkers and hippocampal volume. Stroke (2013) 0.82
Acute phase response in the diagnosis of bacterial infections in children. Pediatr Infect Dis J (2004) 0.82
Clozapine-induced systemic lupus erythematosus. Ann Pharmacother (2006) 0.82
Myocardial revascularization for acute myocardial infarction: benefits and drawbacks of avoiding cardiopulmonary bypass. Ann Thorac Surg (2003) 0.82
Gender difference in C-reactive protein concentrations in individuals with atherothrombotic risk factors and apparently healthy ones. Biomarkers (2004) 0.82
Comparison of bilateral thoracic artery grafting with percutaneous coronary interventions in diabetic patients. Ann Thorac Surg (2004) 0.82
Benign hereditary leukopenia-neutropenia does not result from lack of low grade inflammation. A new look in the era of microinflammation. Blood Cells Mol Dis (2005) 0.81
Graft of choice to right coronary system in left-sided bilateral internal thoracic artery grafting. Ann Thorac Surg (2003) 0.81
Correlated expression of high-sensitivity C-reactive protein in relation to disease activity in inflammatory bowel disease: lack of differences between Crohn's disease and ulcerative colitis. Digestion (2006) 0.81
The diagnostic yield of D-Dimer in relation to time from symptom onset in patients evaluated for venous thromboembolism in the emergency medicine department. J Thromb Thrombolysis (2011) 0.81
Heparin added to cardioplegic solution inhibits tumor necrosis factor-alpha production and attenuates myocardial ischemic-reperfusion injury. Chest (2005) 0.81
What do we mean when we write "senescence," "apoptosis," "necrosis," or "clearance of dying cells"? Ann N Y Acad Sci (2010) 0.81
Red blood cell adhesiveness/aggregation, C-reactive protein, fibrinogen, and erythrocyte sedimentation rate in healthy adults and in those with atherosclerotic risk factors. Am J Cardiol (2002) 0.80
High-sensitivity C-reactive protein measurements in patients with non-arteritic anterior ischaemic optic neuropathy: a clue to the presence of a microinflammatory response. Acta Ophthalmol (2008) 0.80
Elevated levels of CRP in ovarian hyperstimulation syndrome: an unrecognised potential hazard? BJOG (2005) 0.80
A prospective study of the association between obesity and burnout among apparently healthy men and women. J Occup Health Psychol (2008) 0.80
Thrombospondin-1-N-terminal domain induces a phagocytic state and thrombospondin-1-C-terminal domain induces a tolerizing phenotype in dendritic cells. PLoS One (2009) 0.80
Comparative analysis of homocysteine concentrations in patients with retinal vein occlusion versus thrombotic and atherosclerotic disorders. Blood Coagul Fibrinolysis (2008) 0.80
Rheological determinants in patients with Gaucher disease and internal inflammation. Am J Hematol (2004) 0.79
Calcium, leukocyte cell death and the use of annexin V: fatal encounters. Apoptosis (2007) 0.79
Dissociation between mature phenotype and impaired transmigration in dendritic cells from heparanase-deficient mice. PLoS One (2012) 0.79
Technical aspects of composite arterial grafting with double skeletonized internal thoracic arteries. Chest (2003) 0.79
Inflammation-related erythrocyte aggregation in patients with inflammatory bowel disease. Dig Dis Sci (2005) 0.79
Fetal first-degree heart block, or where to set the confidence limit: comment on the article by Sonesson et al. Arthritis Rheum (2005) 0.79
Association of the -757T>C polymorphism in the CRP gene with circulating C-reactive protein levels and carotid atherosclerosis. Thromb Res (2009) 0.79
Electromechanical impairment of human auricle and rat myocardial strip subjected to exogenous oxidative stress. Eur J Cardiothorac Surg (2003) 0.79
Erythrocyte aggregation as an early biomarker in patients with asymptomatic carotid stenosis. Dis Markers (2008) 0.79
The degree of red blood cell aggregation on peripheral blood glass slides corresponds to inter-erythrocyte cohesive forces in laminar flow. Thromb Res (2004) 0.78
Correlated expression of D-dimer concentrations with thrombotic burden in acute pulmonary embolism. Blood Coagul Fibrinolysis (2008) 0.78
Clinical and laboratory characteristics of patients with atherothrombotic risk factors presenting with low concentrations of highly sensitive C-reactive protein. Atherosclerosis (2004) 0.78
Lack of significant effect of low doses of aspirin on the concentrations of C-reactive protein in a group of individuals with atherothrombotic risk factors and vascular events. Blood Coagul Fibrinolysis (2006) 0.78
Persistent hyperfibrinogenemia in acute ischemic stroke / transient ischemic attack (TIA). Thromb Haemost (2008) 0.78
Comparative analysis of Bayer wide-range C-reactive protein (wr-CRP) and the Dade-Behring high sensitivity C-reactive protein (hs-CRP) in patients with inflammatory bowel disease. J Dig Dis (2008) 0.78
Determinants of the erythrocyte sedimentation rate in the era of microinflammation: excluding subjects with elevated C-reactive protein levels. Am J Clin Pathol (2008) 0.78
The effect of ethnic origin on pulmonary prediction equations in a Jewish immigrant population. Respir Med (2008) 0.78
The relationships between self-rated health and serum lipids across time. Int J Behav Med (2012) 0.78
Oncogenic transformation of normal enterocytes by overexpression of cyclin D1. Dig Dis Sci (2003) 0.78
Self-rated health is associated with elevated C-reactive protein even among apparently healthy individuals. Isr Med Assoc J (2015) 0.78
Enhanced erythrocyte aggregation in clinically diagnosed pelvic inflammatory disease. Sex Transm Dis (2005) 0.78
Comparison of values of wide-range C-reactive protein to high-sensitivity C-reactive protein in patients undergoing coronary angiography. Am J Cardiol (2007) 0.78